학술논문

Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study
Document Type
Article
Source
In: eBioMedicine. (eBioMedicine, January 2024, 99)
Subject
Language
English
ISSN
23523964